Captor Capital Corp banner

Intrinsic Value

The intrinsic value of Captor Capital Corp (NMV) under the Base Case is 0.027 EUR per share. Compared with the current market price of 0.032 EUR, the stock appears Overvalued by 15% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

NMV Intrinsic Value
€0.027
Overvaluation 15%
Intrinsic Value
Price €0.032
C
Monitor NMV
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €0.02
Get notified when the price drops into your buy zone
Current Price €0.03
Intrinsic Value €0.03
Margin of Safety 20% €0.02
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to NMV

Fundamental Analysis

What Captor Capital Does

Pharmaceuticals Health Care

Captor Capital Corp. is a Canadian vertically integrated cannabis company, which engages in providing cannabis products and other cannabis-based goods. The objective of the Company is to provide its shareholders with long-term capital growth by investing in a portfolio of cannabis-focused companies and other industries. The activities of the Company, which consist of the acquisition of investments in a diversified portfolio of public companies and commodities, are financed through cash, as well as the completion of equity offerings and the exercise of stock options and warrants.

Headquarters
Canada CA
IPO date
Oct 30, 2017
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Captor Capital Corp

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one NMV stock?

The intrinsic value for Captor Capital Corp (NMV) under the Base Case is 0.027 EUR.

Is NMV stock undervalued or overvalued?

Compared with the current market price of 0.032 EUR, the stock appears Overvalued by 15% .

Back to Top